Real-World Studies Demonstrate Low Event Rates for the SYNERGY Bioabsorbable Polymer (BP) Stent

The SYNERGY BP Stent demonstrated the numerically lowest stent thrombosis rates compared to other DES, despite being used in patients with more complex disease.1 The SCAAR registry is a national, 20-hospital registry of data relating to stent performance in Sweden.

Lowest stent thrombosis rate compared to newer generation DES (n-DES) despite use in patients with statistically more Class B2/C Lesions, Diabetes, Prior PCI, and 3VD.1